Capsiate treatment in liver surgeries may compromise its recovery
AUTOR(ES)
Barros, Pedro Paulo, Gonçalves, Gisele Mara Silva, Silva, Gustavo Henrique da, Bastos, Maria Clara Villaça Dias, Ramos, Loren Nogaroto, Fernandes, Marilia Marinello
FONTE
Acta Cir. Bras.
DATA DE PUBLICAÇÃO
2018-05
RESUMO
Abstract Purpose: To investigate the effects of capsiate treatment on hepatic hyperplasia in partially hepatectomized rats. Methods: The animals were divided into a Capsiate group (CPH), a Capsiate Post-Partial Hepatectomy group (CPPH) and a Partial Hepatectomy Control group (PH). CPH and CPPH animals received 60 mg/kg/day Capsiate for 30 days. Next, the rats underwent partial hepatectomy. CPPH animals continued to receive treatment for 48 h after partial hepatectomy. Liver tissue and intracardiac blood samples were obtained 24 or 48 h after PH. Results: Capsiate treatment interfered with hepatic parameters, reducing the number of mitoses and apoptosis and increasing blood ALT and alkaline phosphatase concentrations. Conclusion: Capsiate treatment preceding hepatic surgery may compromise the initial period of postoperative recovery.
Documentos Relacionados
- Structured intermittent treatment for HIV disease: Necessary concession or premature compromise?
- Advances in treatment may affect cost effectiveness analysis
- LIVER IN THE TREATMENT OF ANÆMIA
- Anti-hepatitis C virus treatment may prevent the progression of liver fibrosis in non-responder human immunodeficiency virus/hepatitis C virus coinfected patients
- Recovery of human foetal liver cells after storage in liquid nitrogen.